VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

NCT01134484 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Velcade
DRUG: Thalidomide
DRUG: Dexamethasone
PROCEDURE: Peripheral Blood Stem Cell (PBSC) collection
PROCEDURE: First Autologous Transplantation
PROCEDURE: Second Autologous Transplantation

Sponsor

Michele Cavo

Collaborators

[object Object]